{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T03:54:25Z","timestamp":1789962865960,"version":"4.0.1"},"reference-count":25,"publisher":"American Physiological Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Physiology-Regulatory, Integrative and Comparative Physiology"],"published-print":{"date-parts":[[2009,3]]},"abstract":"<jats:p>Diabetes is a growing public health concern, and animal models of this disease are necessary for a full understanding of disease pathogenesis, progression, clinical sequelae, and treatment options. In particular, nonhuman primate models of diabetes are important because of their close genetic relationship to humans. Although numerous Old World primate models have been described, few studies have examined the possibility of using New World monkeys as an animal model for this disease. Streptozotocin (STZ) is a common diabetogenic drug that selectively destroys beta cells after uptake via the GLUT2 glucose transporter. Induction of diabetes using STZ was attempted in common marmosets ( Callithrix jacchus). These animals showed increases in blood glucose consistent with diabetes only at STZ doses markedly greater than those used in other primate species. Additionally, all animals showed pathological evidence of acute renal and liver toxicity secondary to the treatment. In a subsequent comparative study of various nonhuman primates, GLUT2 immunostaining in pancreatic islets was used as a marker for sensitivity to STZ. Immunostaining of islets from a variety of nonhuman primate species indicated a reduced expression of pancreatic GLUT2 in New compared with Old World monkeys; this finding explains their resistance to diabetic induction with STZ. Furthermore, there were age-dependent differences in GLUT2 expression, with aged and infant macaques showing reduced expression. We conclude that New World monkeys are an inappropriate model for diabetes induction with STZ and that, with all primate species, it is important to consider the animals\u2019 age before diabetic induction with STZ is attempted.<\/jats:p>","DOI":"10.1152\/ajpregu.90694.2008","type":"journal-article","created":{"date-parts":[[2008,12,11]],"date-time":"2008-12-11T02:38:35Z","timestamp":1228963115000},"page":"R786-R793","source":"Crossref","is-referenced-by-count":21,"title":["Differential expression of GLUT2 in pancreatic islets and kidneys of New and Old World nonhuman primates"],"prefix":"10.1152","volume":"296","author":[{"given":"Joshua","family":"Kramer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth Ludlage","family":"Moeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audra","family":"Hachey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith G.","family":"Mansfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn M.","family":"Wachtman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"24","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3089.2007.00406.x"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000189712.74495.82"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1007\/s001250051564"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-002-0955-x"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-003-1241-2"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-815724"},{"key":"R7","unstructured":"Hansen B, Tigno X.The rhesus monkey (Macaca mulatta) manifests all features of human type 2 diabetes. In:Animal Models of Diabetes: Frontiers in Research, edited by Shafrir E. Boca Raton, FL: CRC, 2007, p. 251\u2013270."},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.53.5.532"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2001.6145"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(02)01918-5"},{"key":"R11","doi-asserted-by":"crossref","unstructured":"Jonasson O, Jones CW, Bauman A, John E, Manaligod J, Tso MO.The pathophysiology of experimental insulin-deficient diabetes in the monkey. Implications for pancreatic transplantation.Ann Surg201: 27\u201339, 1985.","DOI":"10.1097\/00000658-198520110-00005"},{"key":"R12","unstructured":"Kavanaugh K, Flynn M, Zhang L, Collins J, Rankin S, Sajuthi A, Butler PC, Wagner JD.Development of a nonhuman primate model of type 1 diabetes in African green monkeys (Abstract).JAALAS46: 126, 2007."},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1007\/s001250051309"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.1995.0078"},{"key":"R15","doi-asserted-by":"crossref","unstructured":"Rerup CC.Drugs producing diabetes through damage of the insulin secreting cells.Pharmacol Rev22: 485\u2013518, 1970.","DOI":"10.1016\/S0031-6997(25)06885-1"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1097\/01.mpa.0000235307.04110.a2"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.2337\/diab.43.11.1326"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2007.35"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199908150-00003"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.1996.270.4.G541"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.1080\/09687680110100995"},{"key":"R22","unstructured":"Weiss RB.Streptozocin: a review of its pharmacology, efficacy, and toxicity.Cancer Treat Rep66: 427\u2013438, 1982."},{"key":"R23","unstructured":"White JA, Bolstridge MC, Downing HJ, Helm EH, Klomfass HJ.Diabetogenic drugs in the vervet monkey.S Afr Med J48: 273\u2013276, 1974."},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1079\/BJN2002763"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1210\/endo.143.7.8901"}],"container-title":["American Journal of Physiology-Regulatory, Integrative and Comparative Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.physiology.org\/doi\/pdf\/10.1152\/ajpregu.90694.2008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T03:55:49Z","timestamp":1738814149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.physiology.org\/doi\/10.1152\/ajpregu.90694.2008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["10.1152\/ajpregu.90694.2008"],"URL":"https:\/\/doi.org\/10.1152\/ajpregu.90694.2008","relation":{},"ISSN":["0363-6119","1522-1490"],"issn-type":[{"value":"0363-6119","type":"print"},{"value":"1522-1490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}